In the News | Friends of Cancer Research

You are here

In the News

December 3, 2019
Executive Summary The Senate HELP Committee votes 18-5 to send Stephen Hahn's nomination to head the US FDA to the full chamber, although a few senators raised concerns over Hahn's responses to... Read more
December 3, 2019
The Senate Health, Education, Labor and Pensions Committee voted 18 to 5 to advance the nomination of cancer doctor and radiation oncologist Stephen Hahn to lead the U.S. Food and Drug Administration... Read more
December 3, 2019
A Senate committee handily voted in favor of confirming MD Anderson’s Stephen Hahn as the next official FDA commissioner, succeeding the inimitable Scott Gottlieb. And he was whisked through the 18-5... Read more
December 3, 2019
The Senate Health, Education, Labor and Pensions (HELP) Committee on Tuesday voted 18 to 5 to advance the nomination of Stephen Hahn to be the next US Food and Drug Administration (FDA) commissioner... Read more
December 3, 2019
A Senate committee on Tuesday advanced the nomination of Dr. Stephen Hahn, a noted oncologist and cancer researcher, to lead the Food and Drug Administration.   Dr. Hahn, chief medical executive at... Read more
December 2, 2019
More than 40 health and advocacy organizations penned a letter to lawmakers expressing support for Stephen Hahn to be the new FDA commissioner and calling for a swift confirmation. The groups sent... Read more
December 1, 2019
Executive Summary Rigorous planning and a multidisciplinary team including database experts and healthcare specialists with local knowledge are vital to effective real-world evidence, white paper... Read more
November 25, 2019
Tumor mutational burden (TMB) has generated interest as a potential biomarker of response to immunotherapy and has already been examined in the context of several lung cancer trials to gauge its... Read more
November 25, 2019
Friends of Cancer Research (Friends) recently announced the launch of its latest project, ctMoniTR. This pilot project will aim to harmonize the use of circulating tumor DNA (ctDNA) to monitor... Read more

Pages